Tandem Diabetes Care Inc at Cowen Healthcare Conference (Virtual) Transcript
All right. Good morning, everyone. I'm Chris Lin, one of the Cowen's healthcare analysts. It is my pleasure to welcome Tandem Diabetes Care to our conference.
From the company, we have John Sheridan, who is President and CEO; and Leigh Vosseller, who is CFO. I believe John has a few minutes of prepared remarks before we jump into the Q&A session.
So with that, why don't I just hand it over to John.
Thanks, Chris. It's great to be here today. I guess, I'd just like to start off by kind of just recapping some of the comments we made in our call this past week. We had a fantastic 2020. We eclipsed -- almost eclipsed $0.5 billion in sales. We had over 200,000 people using our pump worldwide, which is -- it's almost halfway there to what we said we would accomplish in the next 3 to 5 years. So we're very excited about that.
We obviously got the UNC
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |